These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 25764250)

  • 1. Commentary: Cohort studies of the efficacy of screening for cancer.
    Weiss NS
    Epidemiology; 2015 May; 26(3):362-4. PubMed ID: 25764250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer screening: the clash of science and intuition.
    Kramer BS; Croswell JM
    Annu Rev Med; 2009; 60():125-37. PubMed ID: 18803476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of early diagnosis and treatment of cancer].
    Dong ZW; Qiao YL; Wang GQ
    Zhonghua Zhong Liu Za Zhi; 2012 Aug; 34(8):637-40. PubMed ID: 23159003
    [No Abstract]   [Full Text] [Related]  

  • 4. Screening for cancer: evaluating the evidence.
    Gates TJ
    Am Fam Physician; 2001 Feb; 63(3):513-22. PubMed ID: 11272300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invited commentary: screening as a nuisance variable in cancer epidemiology: methodological considerations.
    Joffe MM
    Am J Epidemiol; 2003 Jun; 157(11):962-4. PubMed ID: 12777357
    [No Abstract]   [Full Text] [Related]  

  • 6. Healthy volunteer effect in a lung cancer screening study.
    Vehmas T; Oksa P
    Eur J Cancer Prev; 2015 Sep; 24(5):454. PubMed ID: 26214089
    [No Abstract]   [Full Text] [Related]  

  • 7. Assessment of Temporal Selection Bias in Genomic Testing in a Cohort of Patients With Cancer.
    Kehl KL; Schrag D; Hassett MJ; Uno H
    JAMA Netw Open; 2020 Jun; 3(6):e206976. PubMed ID: 32511717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Observational Studies That Seek to Emulate a Randomized Trial of Screening to Reduce the Incidence of Cancer: Do They Address the Question to Which We'd Like to Have an Answer?
    Weiss NS
    Am J Epidemiol; 2019 Oct; 188(10):1761-1763. PubMed ID: 30608515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection bias may be the main cause of increased cancer incidence among diabetics: results from the Rotterdam Study.
    De Bruijn KM; Ruiter R; de Keyser CE; Hofman A; Stricker BH; van Eijck CH
    Eur J Cancer; 2014 Sep; 50(14):2449-55. PubMed ID: 25047425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cancer and aging: an epidemiological fact].
    Di Silvestro K; Pautex S; Pugliesi A
    Rev Med Suisse; 2011 May; 7(296):1149-50, 1152-3. PubMed ID: 21721206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits and risks of colorectal cancer screening.
    Riemann JF; Schröder C; Kallenbach M; Giersiepen K; Schmoll HJ
    Oncol Res Treat; 2014; 37 Suppl 3():11-20. PubMed ID: 25195828
    [No Abstract]   [Full Text] [Related]  

  • 12. Glossary of essential terms used in cancer screening.
    Autier P
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S171-5. PubMed ID: 21943971
    [No Abstract]   [Full Text] [Related]  

  • 13. Commentary: Screening: a seductive paradigm that has generally failed us.
    Gøtzsche PC
    Int J Epidemiol; 2015 Feb; 44(1):278-80. PubMed ID: 25596213
    [No Abstract]   [Full Text] [Related]  

  • 14. Solving the overdiagnosis dilemma.
    Esserman L; Thompson I
    J Natl Cancer Inst; 2010 May; 102(9):582-3. PubMed ID: 20413743
    [No Abstract]   [Full Text] [Related]  

  • 15. Cancer screening program in Georgia (results of 2011).
    Gvamichava R; Lomtadze N; Alibegashvili T; Charkviani T; Beruchashvili T; Jugeli L
    Georgian Med News; 2012 Jul; (208-209):7-15. PubMed ID: 22899405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case-control studies of screening efficacy: the use of persons newly diagnosed with cancer who later sustain an unfavorable outcome.
    Weiss NS; Lazovich D
    Am J Epidemiol; 1996 Feb; 143(4):319-22. PubMed ID: 8633615
    [No Abstract]   [Full Text] [Related]  

  • 17. Time to abandon early detection cancer screening.
    Adami HO; Kalager M; Valdimarsdottir U; Bretthauer M; Ioannidis JPA
    Eur J Clin Invest; 2019 Mar; 49(3):e13062. PubMed ID: 30565674
    [No Abstract]   [Full Text] [Related]  

  • 18. [Epidemiology of cancers with implemented screening programmes in an international comparison].
    Dušek L; Mužík J; Malúšková D; Gregor J
    Klin Onkol; 2014; 27 Suppl 2():40-8. PubMed ID: 25494888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing for occult cancer in patients with pulmonary embolism: results from a screening program and a two-year follow-up survey.
    Jara-Palomares L; Rodríguez-Matute C; Elías-Hernández T; Rodríguez-Portal JA; López-Campos JL; Garcia-Ibarra H; Barrot-Cortés E; Otero-Candelera R
    Thromb Res; 2010 Jan; 125(1):29-33. PubMed ID: 19447476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bias in breast cancer research in the screening era.
    Cox B; Sneyd MJ
    Breast; 2013 Dec; 22(6):1041-5. PubMed ID: 23988397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.